an activating mutation in akt-1 or increased dosage of akt-1(+) can bypass the normal requirement for AGE-1 PI3K signaling but still partially depends on DAF-2 signaling,
showing that akt-1 is the major output of PI3K signaling but not the only output of the DAF-2 insulinlike receptor